Table III.
Summary of the meta-analyses for each indicator of the National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATPIII)
| Analysis item | Studiesn | Heterogeneity |
Analysis model | Statistical method | WMD (95% CI) | p-value | |
|---|---|---|---|---|---|---|---|
| I2 | p-value | ||||||
| Body mass index (kg/cm2) | 12 | 73.0% | < 0.001 | Random effect | DerSimonian–Laird method | 1.22 (0.62, 1.81) | 0.002 |
| Waist circumference (cm) | 13 | 82.6% | < 0.001 | Random effect | DerSimonian–Laird method | 4.53 (2.53, 6.53) | 0.001 |
| Triglyceride (mg/dl) | 15 | 92.2% | < 0.001 | Random effect | DerSimonian–Laird method | 19.33 (7.16, 31.49) | 0.025 |
| High-density lipoprotein cholesterol (mg/dl) | 13 | 84.0% | < 0.001 | Random effect | DerSimonian–Laird method | –2.57 (–4.29, –0.86) | 0.025 |
| Fasting blood sugar (mg/dl) | 13 | 84.1% | < 0.001 | Random effect | DerSimonian–Laird method | 6.51 (2.85, 10.17) | 0.011 |
| Systolic blood pressure (mmHg) | 13 | 94.1% | < 0.001 | Random effect | DerSimonian–Laird method | 7.94 (4.90, 10.98) | 0.003 |
| Diastolic blood pressure (mmHg) | 13 | 79.0% | < 0.001 | Random effect | DerSimonian–Laird method | 4.66 (3.41, 5.91) | < 0.001 |
WMD: weighted mean difference; 95% CI: 95% confidence interval.